JeremyHodsonPettusMD

Endocrinology • San Diego, CA

Diabetes, Lipid Metabolism

Physician

Join to view full profile

Dr. Pettus is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pettus' full profile

Already have an account?

Office
200 W Arbor Dr
San Diego, CA 92103
Phone+1 858-657-1636

Fax+1 858-657-1626

Education & Training

Boston University School of MedicineClass of 2007
University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism

Certifications & Licensure

CA State Medical License 2008 - 2026
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Publications & Presentations

PubMed

30 citations
Risk of new-onset type 2 diabetes in 600 055 people after COVID-19: A cohort study.
Morgan Birabaharan, David C Kaelber, Jeremy H Pettus, Davey M Smith
Diabetes, Obesity & Metabolism. 2022-06-01
128 citations
Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device
A. M. James Shapiro, David M. Thompson, Thomas Donner, Melena D. Bellin, Willa A. Hsueh
Cell Reports. Medicine. 2021-12-02
619 citations
The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Richard I G Holt, J Hans DeVries, Amy Hess-Fischl, Irl B Hirsch, M Sue Kirkman
Diabetologia. 2021-12-01

Lectures

Real Time Continuous Glucose Monitoring (RT-CGM) Users Make Significant Adjustments to Insulin Doses Based on CGM Rate of Change Arrows: Comparison between Users with ...
San Diego, CA - 6/16/2014
Response of Real-Time Continuous Glucose Monitoring (RT-CGM) Users to Rate of Change Arrows: A Comparison of Adults with Type 1 Diabetes (DM1) Using Injections (MDI) a...
San Diego, CA - 6/15/2014

Press Mentions

FDA Advisory Committee Recommends Approval of Immunotherapy to Delay Type 1 DiabetesMay 27th, 2021
How to Drink Responsibly with Type 1 Diabetes (And Enjoy It!)March 15th, 2020
ONE: A New Weekend Conference Retreat for Adults with Type 1 DiabetesJanuary 30th, 2017
Join now to see all